4.Other Non-Current Assets
Other non-current assets consisted of the following (in thousands):
June 30, 2026
December 31, 2025
Clinical trial deposits
$
15,716
12,882
Deferred offering costs
486
709
Other
87
218
Total other assets
16,289
13,809
The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.
No definition available.